Tag: $MiNK Therapeutics

MiNK Therapeutics stock soars after cancer remission breakthrough

MiNK Therapeutics, Inc. (NASDAQ:INKT) stock soared 200% after the company announced a complete remission in a patient with metastatic testicular cancer following treatment with its allogeneic iNKT cell therapy, agenT-797.